“The Immunoreactivity of Uroplakin III in Urothelial Carcinoma of Urinary Bladder and Other Non- Urothelial Carcinoma” (2019) Medico Legal Update, 19(2), pp. 319–323. doi:10.37506/mlu.v19i2.796.